RGD-La
General Information
DCTPep ID DCTPep00406
Peptide Name RGD-La
Sequence RGDLLRHVVKILEKYL
Sequence Length 16
UniProt ID Not available
PubChem CID Not available
Origin Arg-Gly-Asp(RGD) tripeptide ana temporins
Type Synthetic peptide
Classification
ACP Tumor active peptide Membrane-targeted
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
MEC | Cholangiocarcinoma; Cholangiocarcinoma | 19.76 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
HL-7702(L-02) | Human papillomavirus-related endocervical adenocarcinoma | 36.25 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
A549 | Lung adenocarcinoma | 47.26Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
Hep-G2 | Hepatoblastoma; Hepatoblastoma | 60.22 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
BGC-823 | Human papillomavirus-related endocervical adenocarcinoma | 62.49 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
SMMC-7721 | Human papillomavirus-related endocervical adenocarcinoma | 70.39 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
SW1116 | Colon adenocarcinoma | 72.69 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | 73.09 Inhibition ratio at 50 µg/ml | MTT assay | 24 h | 1 |
Hemolytic Activity Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml
Normal (non-cancerous) Cytotoxicity Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml
Target Not available
Affinity Not available
Mechanism A membrane-disturbing action seems to be the major mechanism for cell death
Structure Information
PDB ID Not available
Predicted Structure DCTPep00406
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C90H154N26O22
Absent amino acids ACFMNPQSTW
Theoretical pI 9.70
Acidic residues 2
Basic residues 5
Polar residues 2
Molecular weight (Average) 1952.37
Molecular weight (Monoisotopic) 1951.17
Common amino acids L
Net charge 3
Instability index (II) 33.08
Aliphatic index 158.12
Grand average of hydropathicity (GRAVY) -0.037
Half Life
1 hours (mammalian reticulocytes, in vitro).
2 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 0.763
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22641352
Title Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain
Doi 10.1002/psc.2420
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available